Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXERCALCIFEROL vs PARICALCITOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOXERCALCIFEROL vs PARICALCITOL: Safety Overview

Metric DOXERCALCIFEROL PARICALCITOL
Total FAERS Reports 137 6,665
Deaths Reported 7 4,801
Death Rate 5.1% 72.0%
Hospitalizations 34 1,662
Average Patient Age 54.9 yrs 57.8 yrs
% Female Patients 50.0% 43.1%
FDA Approval Date Apr 23, 2004 Apr 17, 1998
Manufacturer Alembic Pharmaceuticals Inc. Aurobindo Pharma Limited
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription